ORLANDO, FL, USA (UroToday.com) - For patients with high-risk prostate cancer, radiotherapy (RT) and long term androgen blockade (AB) is standard treatment but the optimal duration of treatment has not yet been determined.
Login to update email address, newsletter preferences and use bookmarks.
Email
Password